about
Vitamin B and its derivatives for diabetic kidney diseaseVitamin B and/or its derivatives for diabetic kidney diseaseAngiotensin II induced inflammation in the kidney and in the heart of double transgenic ratsMidkine in nephrogenesis, hypertension and kidney diseasesTherapeutic modalities in diabetic nephropathy: standard and emerging approaches.Polarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-cateninAldosterone as a determinant of cardiovascular and renal dysfunctionAngiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonistRenal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1'Special k' and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: modulation of the adherens junction complex by ketamineTWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21Management of Diabetic Nephropathy in the Elderly: Special Considerations.Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort studyTherapeutic Modalities in Diabetic Nephropathy: Future Approaches.Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney.Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of HypertensionInduction of glia maturation factor-beta in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities.Determination of atrasentan by high performance liquid chromatography with fluorescence detection in human plasma.Protein profiling of urine from dogs with renal disease using ProteinChip analysis.Randomized, double-blind, controlled study of losartan in children with proteinuria.Retrospective Comparison of Estimated GFR using 2006 MDRD, 2009 CKD-EPI and Cockcroft-Gault with 24 Hour Urine Creatinine ClearanceHepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.Progressive renal insufficiency. Office strategies to prevent or slow progression of kidney disease.The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidneyRenal protective potential of antihypertensive drugs.Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.Podocyte is the major culprit accounting for the progression of chronic renal disease.Nephrology: 4. Strategies for the care of adults with chronic kidney disease.Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cellsUrinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubulesProtective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.Calcium channel blockers in the prevention of end stage renal disease: a review.The potential of endothelin antagonism as a therapeutic approach.Microalbuminuria: definition, detection, and clinical significance.Transforming growth factor beta contributes to progressive diabetic nephropathyAlbumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells.NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease.
P2860
Q24186641-2887994C-0E6A-4B2E-90BD-72A47D3A30D5Q24236375-55178C6A-35BF-4055-9517-FB4FBA526D50Q24800784-001BCA34-B346-454A-AF92-D2A40E9EEE21Q27006801-2759170A-8CCA-41DC-BC32-D64DB8372F35Q27007027-61F0B790-C0CE-4003-8048-1F064DBFF694Q28236038-9705F2B2-A14A-4A84-9209-7F934580C62AQ28344356-2666DB57-0040-428B-B9BB-3AE178CD6831Q28363381-A9E364EF-AE6E-4589-A516-9680A25517E3Q28363418-4EFFF332-5621-4CE6-8296-6A9B4EBE4DEDQ28535969-EFD7DCC4-65A0-4140-A8BC-F4F4F0126D4CQ28749137-3A33EA88-EBE7-4D14-ADAA-65760C011BC8Q30353386-793C075F-501E-4063-B61A-04CF016425ACQ30419884-102388B5-7727-4363-8AA1-F244877C57D7Q30423005-0A5C05BF-2BAC-4DE2-AEBA-F113282D4242Q30444863-AA5BC505-8404-4E9F-8C98-7C9706E5BFE2Q30499043-F22E33F6-A377-4BFD-A96F-68571D315751Q30499045-D334CE6F-FF8F-45F2-B63F-4346BD441178Q31145011-9B0A6A80-6E91-4874-BD41-60AC2657FF40Q32049427-74A751D0-6C7F-4D93-ADA2-3C17865B79B3Q33205784-A90F1E48-DFA9-49B9-8707-43D2CDF22996Q33683988-087A04FE-B526-4978-A0C7-7BD04BDA0B43Q33831828-BE96D4DF-5110-4DE4-8714-AAC45DECA5DAQ33913784-9C3A3DD5-50AD-40AF-9465-010CF9D6C951Q33983309-EC951F3C-FC1E-4500-8D6B-9F18ECF8EACCQ34021381-9270C488-5880-4351-9CFC-5091533C28C9Q34075168-3A0FE093-3847-40FD-AB29-58BAD0A5C7F2Q34449421-4B268738-3FCB-4F5E-B2B8-9EC0B516BDD0Q34617366-4D61CC93-9FAB-4857-9B5F-B824160D03ABQ34638667-E70AAC50-9D78-4553-8C0A-3658588CE9D2Q35031111-B7D9CFF5-4008-4934-B419-D84C06FF46DEQ35097995-358BD60F-781B-402A-B793-87838F927E22Q35103241-1018B394-9808-4059-A531-7ECEFEA72229Q35468668-F4DC4511-E518-42EF-8B41-75943AA8E496Q35738806-55C73114-7947-412B-8E8D-A50501CBE8C5Q35925573-BC9DC6AA-542B-4899-8646-C0442B9E9AFBQ35945733-0F1CD88B-1F52-4204-A2DA-49036B8221E1Q36102963-C7C321F1-89EC-4C70-AE91-D854AFD15C4BQ36175356-ACCBCA2D-C164-4915-8B20-707223B1189DQ36293005-FA75D173-212B-443A-AC15-4FCC7360CC07Q36458972-0FD733FE-026A-4431-8890-35F952FCE43B
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Understanding the nature of renal disease progression.
@en
type
label
Understanding the nature of renal disease progression.
@en
prefLabel
Understanding the nature of renal disease progression.
@en
P50
P356
P1433
P1476
Understanding the nature of renal disease progression.
@en
P2888
P356
10.1038/KI.1997.2
P407
P577
1997-01-01T00:00:00Z